tiprankstipranks
Trending News
More News >
Corvus Pharmaceuticals Inc (CRVS)
NASDAQ:CRVS
US Market

Corvus Pharmaceuticals (CRVS) Balance Sheet

Compare
643 Followers

Corvus Pharmaceuticals Balance Sheet

Corvus Pharmaceuticals's total assets for Q3 2025 were $80.47M, a decrease of -10.05% from the previous quarter. CRVS total liabilities were $8.71M for the fiscal quarter, a -5.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 68.91M$ 45.55M$ 68.24M$ 109.45M$ 85.53M
Total Liabilities
$ 36.34M$ 6.87M$ 12.13M$ 12.29M$ 13.38M
Total Equity Gross Minority
$ 32.57M$ 38.68M$ 56.12M$ 97.16M$ 72.15M
Other Metrics
Currency in USD

Corvus Pharmaceuticals Debt to Assets